Back to News
Market Impact: 0.1
Spero Therapeutics, Inc. Announces Retirement of Chief Operating Officer Timothy Keutzer
Source: Nasdaq
Management & Governance
Spero Therapeutics said COO Timothy Keutzer will retire effective December 31, 2026. The company expects to enter into a consulting arrangement with him; the article text does not provide further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- FedEx beats expectations, raises outlook in first report since calendar adjustment
- Warsh says politics played no role in Fed’s rate decision by group he is ’honored’ to lead
- Tencent’s Cloud Boss Plays Long Game to Patch ‘Leaky’ AI Ship
- ECB to hold rates as investors focus on French bonds, Lagarde’s future
- Microsoft reveals strong cloud growth amid financial reporting overhaul
- Bloomberg, 2 trading firms subscribe to faster access to Trump posts- Reuters